tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Haleon PLC Advances Share Buyback Program with New Purchase

Story Highlights
Haleon PLC Advances Share Buyback Program with New Purchase

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Haleon PLC ( (GB:HLN) ) has issued an update.

Haleon PLC announced the purchase of 3,251,858 ordinary shares as part of its ongoing share buyback program. This move is part of the second tranche of the program, initially announced in July 2025. The shares will be held as treasury shares, impacting the company’s share capital and voting rights. This strategic financial maneuver is likely aimed at enhancing shareholder value and optimizing capital structure, reflecting Haleon’s commitment to maintaining a robust financial position.

The most recent analyst rating on (GB:HLN) stock is a Hold with a £3.80 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.

Spark’s Take on GB:HLN Stock

According to Spark, TipRanks’ AI Analyst, GB:HLN is a Outperform.

Haleon PLC’s overall stock score reflects a strong financial foundation with robust profitability and cash flow management. However, technical indicators and valuation suggest a more cautious outlook. The earnings call highlighted regional strengths but also significant challenges in North America, impacting the overall sentiment. The absence of notable corporate events leaves the focus on financial and operational performance.

To see Spark’s full report on GB:HLN stock, click here.

More about Haleon PLC

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company’s product portfolio includes Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.

Average Trading Volume: 20,257,537

Technical Sentiment Signal: Sell

Current Market Cap: £29.7B

Learn more about HLN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1